| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |